(Q36584354)

15 August 2017

1 reference

title

Chapter 2: The burden of HPV-related cancers (English)

1 reference

15 August 2017

D Maxwell Parkin

1

1 reference

15 August 2017

Freddie Bray

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

24 Suppl 3

1 reference

15 August 2017

page(s)

S3/11-25

1 reference

Cancer occurrence in Ardabil: Results of a population-based Cancer Registry from Iran

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Cancer survival in a southern African urban population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

History of circumcision, medical conditions, and sexual activity and risk of penile cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Mortality of wives of men dying with cancer of the penis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Cancer incidence correlations: genital, urinary and some tobacco-related cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

At least one in seven cases of cancer is caused by smoking. Global estimates for 1985.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Heterogeneous etiology of squamous carcinoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Clinicopathologic features and human papillomavirus dna prevalence of warty and squamous cell carcinoma of the penis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

The global health burden of infection-associated cancers in the year 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

A population-based study of squamous cell vaginal cancer: HPV and cofactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Cohort mortality from carcinoma of the cervix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

The estimation of age, period and cohort effects for vital rates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Trends in cancer of the cervix uteri in Sweden following cytological screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

The cervical cancer epidemic that screening has prevented in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

In situ and invasive vulvar cancer incidence trends (1973 to 1987)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Changing patterns of anal cancer incidence in the United States, 1940-1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Evaluating human papillomavirus vaccination programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

Predicting the future burden of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.111

10.1016/J.VACCINE.2006.05.111

7 January 2021

Identifiers

DOI

1 reference

release_lgwd66lr6vf6bfmidmwatq247u

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lgwd66lr6vf6bfmidmwatq247u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference